SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 455 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.01 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,105 | +5.8% | 9,116 | 0.0% | 0.02% | +5.3% |
| Q2 2023 | $1,044 | -10.0% | 9,116 | +8.3% | 0.02% | -13.6% |
| Q1 2023 | $1,160 | +6.3% | 8,416 | 0.0% | 0.02% | +4.8% |
| Q4 2022 | $1,091 | -99.9% | 8,416 | 0.0% | 0.02% | +10.5% |
| Q3 2022 | $930,000 | +5.9% | 8,416 | -28.2% | 0.02% | -5.0% |
| Q2 2022 | $878,000 | -5.3% | 11,716 | -1.3% | 0.02% | +11.1% |
| Q1 2022 | $927,000 | -8.9% | 11,866 | +5.0% | 0.02% | -5.3% |
| Q4 2021 | $1,018,000 | -3.0% | 11,300 | -0.4% | 0.02% | -13.6% |
| Q3 2021 | $1,050,000 | +22.8% | 11,350 | +3.2% | 0.02% | +10.0% |
| Q2 2021 | $855,000 | +8.2% | 11,000 | +3.8% | 0.02% | 0.0% |
| Q1 2021 | $790,000 | -43.9% | 10,600 | +28.5% | 0.02% | -52.4% |
| Q4 2020 | $1,407,000 | -99.4% | 8,250 | +44.7% | 0.04% | +180.0% |
| Q4 2015 | $219,906,000 | – | 5,700 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 1,010,330 | $122,472,203 | 13.56% |
| Finepoint Capital LP | 145,357 | $17,620,176 | 8.78% |
| Avoro Capital Advisors LLC | 4,025,000 | $487,910,500 | 7.61% |
| Saturn V Capital Management LP | 118,401 | $14,352,569 | 6.01% |
| Ghost Tree Capital, LLC | 150,000 | $18,183,000 | 5.98% |
| Ikarian Capital, LLC | 3,673 | $44,524,106 | 5.36% |
| ACUTA CAPITAL PARTNERS, LLC | 550 | $7,580,650 | 5.08% |
| Eagle Health Investments LP | 174,212 | $21,117,979 | 4.65% |
| Boxer Capital, LLC | 600,000 | $72,732,000 | 3.87% |
| GREAT POINT PARTNERS LLC | 165,200 | $20,025,544 | 3.65% |